Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 69-77 , 2 January 2004

Proteinuria in African Americans with type 1 diabetes

Received 24 October 2002 ,Accepted 16 December 2002.

References 

  1. American Diabetes Association . Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381–389
  2. Andersen A, Christiansen J, Andersen J, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25:496–501
  3. Arfken C, Salicrup A, Meuer S, Del Priore L, Klein R, McGill J, et al. Retinopathy in African-Americans and whites with insulin-dependent diabetes. Archives of Internal Medicine. 1994;154:2597–2602
  4. Barnett A, Dallinger K, Jennings P, Fletcher J, Odugbesan O. Microalbuminuria and diabetic retinopathy. Lancet. 1985;36:53–54
  5. Brancati F, Whittle J, Whelton P, Seidler A, Klag M. The excess incidence of diabetic end-stage renal disease among Blacks. JAMA, Journal of the American Medical Association. 1992;268:3079–3084
  6. Canner P, Borhani N, Oberman A. The hypertension prevention trial: assessment of the quality of blood pressure measurements. American Journal of Epidemiology. 1991;134:339–379
  7. Coonrod B, Ellis D, Becker D, Bunker C, Kelsey S, Lloyd C, et al. Predictors of microalbuminuria in individuals with IDDM. Diabetes Care. 1993;16:1376–1383
  8. Council on Clinical Classifications . International classification of diseases, 9th rev., clinical modification. vol. 1. Ann Arbor, MI: E Brothers; 1978;
  9. Cowie C, Port F, Wolfe R, Savage P, Moll P, Hawthorne V. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. New England Journal of Medicine. 1989;321:1074–1079
  10. Crook E. Diabetic renal disease in African Americans. American Journal of the Medical Sciences. 2002;323(2):78–84
  11. Dasmahapatra A, Bale A, Raghuwanshi M, Reddi A, Byrne W, Suarez S. Incipient and overt diabetic nephropathy in African Americans with NIDDM. Diabetes Care. 1994;17:297–304
  12. Deckert T, Parving H, Thomsen O, Jorgensen F, Brun C, Thonmsen A. Renal structure and function in type 1 (insulin-dependent) diabetic patients: a study of 44 kidney biopsies. Diabetic Nephropathy. 1985;4:163–168
  13. Deckert T, Poulsen J, Larsen M. Prognosis of diabetics with diabetes onset before age of thirty one: I. Survival, causes of death, and complications. Diabetologia. 1978;14:363–370
  14. Delamater A, Albrecht D, Postellon D, Gutai J. Racial differences in metabolic control of children and adolescents with type 1 diabetes. Diabetes Care. 1991;14:20–25
  15. Dunn F. Hyperlipidemia in diabetes mellitus. Diabetes and Metabolism Review. 1990;6:47–61
  16. Early Treatment Diabetic Retinopathy Study Research Group . Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS Report Number 10. Ophthalmology. 1991;98:786–806
  17. Early Treatment Diabetic Retinopathy Study Research Group . Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report Number 12. Ophthalmology. 1991;98:823–833
  18. Ellis D, Coonrod B, Dorman J, Kelsey S, Becker D, Avner DS, et al. Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. American Journal of Kidney Diseases. 1989;13:321–328
  19. Freedman B, Tuttle A, Spray B. Familial predisposition to nephropathy in African-Americans with non-insulin dependent diabetes mellitus. American Journal of Kidney Diseases. 1995;25:710–713
  20. Goldschmid M, Domin W, Ziemer D, Gallina D, Phillips L. Diabetes in urban African-Americans: II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes. Diabetes Care. 1995;18:955–961
  21. Goldthorpe J, Hope K. In: The social grading of occupations: a new approach and scale. New York: Oxford University; 1974;p. 134–143
  22. Haffner S, Klein R, Moss S, Klein B. Sex hormones and the incidence of severe retinopathy in male subjects with type 1 diabetes. Opthalmology. 1993;100:1782–1786
  23. Health Care Financing Administration, Office of Research and Demonstrations . End stage renal disease, 1985: Health Care Financing Research report. Baltimore, MD: U.S. Department of Health and Human Services; 1987;
  24. Kalter-Leibovici O, Van Dyek A, Leibovici L, Loya N, Erman A, Kremer I, et al. Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes. 1991;40:204–210
  25. Klein R, Klein B, Moss S, Cruichshanks K. Ten-year incidence of gross proteinuria in people with diabetes. Diabetes. 1995;44:916–923
  26. Klein R, Klein B, Moss S, Davis M, DeMets D. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: V. Proteinuria and retinopathy in a population of diabetic persons diagnosed prior to 30 years of age. In: Diabetic renal–retinal syndrome. vol. 3:New York: Grune & Stratton; 1986;p. 245–264
  27. Krolewski A, Laffel L, Krolewski M, Quinn M, Warram J. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. New England Journal of Medicine. 1995;332:1251–1255
  28. Krolewski A, Warram J, Christlieb R, Busick E, Kahn R. The changing natural history of nephropathy in type 1 diabetes. American Journal of Medicine. 1985;78:785–794
  29. Krolewski A, Warram J, Rand L, Kahn C. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. New England Journal of Medicine. 1987;317:1390–1397
  30. Laporte R, Tajima N, Dorman J, Cruickshanks K, Eberhardt M, Rabin B, et al. Differences between blacks and whites in the epidemiology of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania. American Journal of Epidemiology. 1986;123:592–603
  31. Levy D, Chopra C, Mettert N, Simon S, Murray E, Hawthorne V. Absence of racial differences in prevalence of early renal disease in male diabetics. Diabetes. 1986;35:72A; supplement, abstract
  32. Lopes A, Hornbuckle K, James S, Port F. The joint effects of age on the risk of end-stage renal disease attributed to hypertension. American Journal of Kidney Diseases. 1994;24:554–560
  33. Mogensen CE. A complete screening of urinary albumin concentration in an unselected diabetic out-patient clinic population. Diabetic Nephropathy. 1983;2:11–18
  34. Neugarten J, Acharya A, Silbiger S. Effect of gender on the progression of diabetic renal disease: a meta-analysis. Journal of the American Society of Nephrology. 2000;11:319–329
  35. Orchard R, Dorman J, Maser R, Becker D, Drash A, Ellis D, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39:1116–1124
  36. Parving H, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. British Medical Journal. 1988;296:156–160
  37. Parving H, Smidt U, Andersen A, Svendsen P. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983;1175–1179
  38. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197
  39. Roy M. Diabetic retinopathy in African-Americans with type 1 diabetes: the New Jersey 725. I. Methodology, population, frequency of retinopathy and visual impairment. Archives of Ophthalmology. 2000;118:97–104
  40. Roy M. Diabetic retinopathy in African-Americans with type 1 diabetics: the New Jersey 725: II. Risk factors. Archives of Ophthalmology. 2000;118:105–115
  41. Roy M, Klein R. Macular edema and retinal hard exudates in African-Americans with type 1 diabetes: the New Jersey 725. Archives of Ophthalmology. 2000;119:251–259
  42. Seaquist E, Goetz F, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. New England Journal of Medicine. 1989;320:1161–1165
  43. Stephenson J, Fuller J  EURODIAB IDDM Complications Study Group . Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia. 1994;37:278–285
  44. Stephenson J, Fuller J, Viberti G, Sholie A, Navalesi R. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM complications Study. Diabetologia. 1995;38:599–603
  45. The Microalbumin Collaborative Study Group . Microalbuminuria in type 1 diabetic patients. Diabetes Care. 1992;15:495–501
  46. Torffvit O, Agardh E, Agardh C. Albuminuria and associated medical risk factors: a cross-sectional study in 476 type 1 (insulin-dependent) diabetic patients: Part 1. Journal of Diabetic Complications. 1991;5(1):23–28
  47. Trevisan R, Viberti G. Genetic factors in the development of diabetic nephropathy. Journal of Laboratory and Clinical Medicine. 1995;126:342–349
  48. Viberti G, Chaturvedi N. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria. Kidney International. 1997;(Suppl. 63):S32–S35
  49. Wagenknecht L, Roseman J, Alexander W. Epidemiology of IDDM in black and white children in Jefferson County, Alabama, 1979–1985. Diabetes. 1989;38:629–633
  50. Winter W, Maclaren N, Riley W, Clarke D, Kappy M, Spillar R. Maturity-onset diabetes of youth in Black Americans. New England Journal of Medicine. 1987;316:285–291

PII: S1056-8727(02)00279-9

doi: 10.1016/S1056-8727(02)00279-9

Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 69-77 , 2 January 2004

Article Tools

* Image Usage & Resolution